The role of choline positron emission tomography/computed tomography in the management of patients with prostate-specific antigen progression after radical treatment of prostate cancer.
about
Surgical resection of urological tumor metastases following medical treatmentUpdate on positron emission tomography for imaging of prostate cancerMetabolic Imaging in Prostate Cancer: Where We ArePET Metabolic Biomarkers for CancerTarget Definition in Salvage Radiotherapy for Recurrent Prostate Cancer: The Role of Advanced Molecular ImagingPET/CT with (11)C-choline for evaluation of prostate cancer patients with biochemical recurrence: meta-analysis and critical review of available data.Pulmonary and chest wall metastasectomy in urogenital tumors: a single center experience and review of literatureImaging evaluation of prostate cancer with 18F-fluorodeoxyglucose PET/CT: utility and limitationsAnti-3-[(18)F]FACBC positron emission tomography-computerized tomography and (111)In-capromab pendetide single photon emission computerized tomography-computerized tomography for recurrent prostate carcinoma: results of a prospective clinical trial.Dual-phase PET-CT to differentiate [18F]Fluoromethylcholine uptake in reactive and malignant lymph nodes in patients with prostate cancerManagement of urological malignancies: Has positron emission tomography/computed tomography made a difference?Detection of recurrent prostate carcinoma with anti-1-amino-3-18F-fluorocyclobutane-1-carboxylic acid PET/CT and 111In-capromab pendetide SPECT/CTAdvanced imaging for the early diagnosis of local recurrence prostate cancer after radical prostatectomy.Targeted salvage lymphadenectomy in patients treated with radical prostatectomy with biochemical recurrence: complete biochemical response without adjuvant therapy in patients with low volume lymph node recurrence over a long-term follow-up.Transbilayer phospholipids molecular imaging.Can Choline PET Tackle the Challenge of Imaging Prostate Cancer?Prospective evaluation of 18F-NaF and 18F-FDG PET/CT in detection of occult metastatic disease in biochemical recurrence of prostate cancerAssessment of Lymph Nodes and Prostate Status Using Early Dynamic Curves with (18)F-Choline PET/CT in Prostate CancerMolecular imaging of prostate cancer: PET radiotracers.Prostate cancer brachytherapy: guidelines overview.(11)C-Choline and FDG PET/CT Imaging of Primary Cholangiocarcinoma: A Comparative Analysis.Preparation and affinity identification of glutamic acid-urea small molecule analogs in prostate cancerEarly assessment of radiation response using a novel functional imaging modality -- [18F]fluorocholine PET (FCH-PET): a pilot study.Role of imaging and biopsy to assess local recurrence after definitive treatment for prostate carcinoma (surgery, radiotherapy, cryotherapy, HIFU).PET and PET/CT in radiation treatment planning for prostate cancer.Advances in imaging and in non-surgical salvage treatments after radiorecurrence in prostate cancer: what does the oncologist, radiotherapist and radiologist need to know?11C-choline PET/CT and PSA kinetics.Imaging treated prostate cancer.Choline PET/CT for imaging prostate cancer: an update.Individualized image-based lymph node irradiation for prostate cancer.Application of C-11-acetate positron-emission tomography (PET) imaging in prostate cancer: systematic review and meta-analysis of the literature.Innovations in diagnostic imaging of localized prostate cancer.Role of focal salvage ablative therapy in localised radiorecurrent prostate cancer.A paradigm shift from anatomic to functional and molecular imaging in the detection of recurrent prostate cancer.Seminal plasma as a diagnostic fluid for male reproductive system disorders.Advances in local and ablative treatment of oligometastasis in prostate cancer.Evolving role of positron emission tomography (PET) in urological malignancy.Imaging biomarkers in prostate cancer: role of PET/CT and MRI.Emerging treatments for recurrent prostate cancer.Imaging and evaluation of patients with high-risk prostate cancer.
P2860
Q27013035-943B8D2A-0D79-453F-BE5C-60EA4D6E3C4EQ27026828-88BB3C31-01D1-4882-9487-1E5A05E65544Q28074429-6A5BBC41-4FC2-48B7-A88A-390FD86FD6A4Q28074449-D7C1794E-C561-4299-9703-7373BA94EFD4Q28074669-6F04D98E-778A-48D4-8DA1-755994073260Q31003607-CEC6542A-EE89-4A6B-9067-89476CF33C80Q33877161-1FA9DFAB-AB48-4397-9F73-CCD859AAC8E1Q34035683-8141B2C2-3F4F-492B-9A96-76DC4A649CFDQ34139498-F5316406-D655-4385-9B0E-22319D1F14E1Q34465066-5B42D932-1297-4C15-B62D-51BE4713B1C4Q34990800-D4F27333-B883-4476-84DD-945F8ABFE427Q34995973-CB3F59B8-9FA0-42E1-9043-C794B0AFC379Q35155500-646403E6-95AE-4C7A-A2CB-0CE7A16C6EB9Q35604502-2A8E7671-39EE-4675-8A12-A7534655C85DQ35650805-C14348C4-83B9-45AD-B138-EE3B807326B4Q35849169-DDB68AA9-1CF5-43D2-B2BF-FC516033E116Q36033412-DE49F1CD-7DB6-416A-83D0-E0E5E2ADB82AQ36039090-169678BC-91F2-4ED5-8EE0-68F4F90A876CQ36129937-8EC0E8E9-9610-44F8-837D-9D1855289C52Q36555616-918D00A2-E082-4985-B3B6-4A5A9A0226FAQ37077299-FBEA71F4-FE3D-4224-A092-604E1829E88CQ37108209-31E3A126-585E-459B-B871-D12A9709B27DQ37254208-DB61AAFA-5D5C-43F2-9F72-26F0EF61444DQ37873396-ED23EF19-F832-46A5-88F9-61E53C2E67DEQ37909361-CDE9353B-7224-4D5F-9474-1A53C58AEAB4Q38026501-31AE0F83-8F95-4677-ADE5-64C20A00DAAEQ38098442-BB0E29A5-A1A0-4561-A94A-C29446E59A4AQ38100661-EA5713AB-9A92-487E-A40B-EB7922AD445CQ38103180-BDE86086-CF05-4430-AD90-22B2DC3B9F3EQ38109812-2D29AA48-E426-43DC-9B13-AD4CAE8CFE0CQ38128388-EA7D39D6-7CC6-4F65-982B-E085C9838900Q38146913-2675A613-CF1C-4163-8839-84B736A20F31Q38152243-E2BBF7D4-46BB-4FB0-9119-5894D45BD652Q38190115-D4F8B4FE-FF1D-470A-A99C-0FD0C0BDCB56Q38202841-0365A13B-059C-4552-AE3D-BA5BBFF79386Q38243113-D46CD82F-DFD5-472F-8ED7-0E28A245931FQ38269763-B65E6785-4512-4F6F-A3B0-723C4EF4B53DQ38321182-C40A5C4C-F96B-4EB4-8C49-27759F3F231AQ38599162-60BE873E-8451-4D8D-9FC1-F8CD5FD88AD5Q38611187-34B7A952-ACAA-4C59-8D15-23170F998184
P2860
The role of choline positron emission tomography/computed tomography in the management of patients with prostate-specific antigen progression after radical treatment of prostate cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 15 September 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The role of choline positron e ...... treatment of prostate cancer.
@en
The role of choline positron e ...... treatment of prostate cancer.
@nl
type
label
The role of choline positron e ...... treatment of prostate cancer.
@en
The role of choline positron e ...... treatment of prostate cancer.
@nl
prefLabel
The role of choline positron e ...... treatment of prostate cancer.
@en
The role of choline positron e ...... treatment of prostate cancer.
@nl
P2093
P50
P1433
P1476
The role of choline positron e ...... treatment of prostate cancer.
@en
P2093
Axel Heidenreich
Bernd J Krause
Cristina Messa
George N Thalmann
Stefano Fanti
Sven N Reske
P356
10.1016/J.EURURO.2010.09.004
P407
P577
2010-09-15T00:00:00Z